JP2023536633A - ヘテロアリール及びヘテロシクリル化合物 - Google Patents
ヘテロアリール及びヘテロシクリル化合物 Download PDFInfo
- Publication number
- JP2023536633A JP2023536633A JP2023507667A JP2023507667A JP2023536633A JP 2023536633 A JP2023536633 A JP 2023536633A JP 2023507667 A JP2023507667 A JP 2023507667A JP 2023507667 A JP2023507667 A JP 2023507667A JP 2023536633 A JP2023536633 A JP 2023536633A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- heteroalkyl
- formula
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060968P | 2020-08-04 | 2020-08-04 | |
| US63/060,968 | 2020-08-04 | ||
| PCT/US2021/044564 WO2022031862A2 (en) | 2020-08-04 | 2021-08-04 | Heteroaryl and heterocyclyl compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536633A true JP2023536633A (ja) | 2023-08-28 |
| JP2023536633A5 JP2023536633A5 (cg-RX-API-DMAC10.html) | 2024-08-14 |
Family
ID=80120142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507667A Pending JP2023536633A (ja) | 2020-08-04 | 2021-08-04 | ヘテロアリール及びヘテロシクリル化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230303502A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4192468A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023536633A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230048523A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116322777A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021321433A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023002132A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3190778A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022031862A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4531879A1 (en) | 2022-05-25 | 2025-04-09 | Flagship Pioneering Innovations VI, LLC | Compositions of secretory and/or catalytic cells and methods using the same |
| JP2025520113A (ja) | 2022-06-03 | 2025-07-01 | フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー | 組成物及び方法 |
| IL328729A (en) | 2023-12-01 | 2026-07-01 | Sigilon Therapeutics Inc | Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012514009A (ja) * | 2008-12-31 | 2012-06-21 | アーデリクス,インコーポレーテッド | 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるnhe媒介性アンチポートを阻害するための組成物および方法 |
| WO2016071856A1 (en) * | 2014-11-06 | 2016-05-12 | Novartis Ag | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
| JP2017524768A (ja) * | 2014-08-01 | 2017-08-31 | マサチューセッツ インスティテュート オブ テクノロジー | 抗線維化材料のための修飾されたアルギネートおよび用途 |
| JP2018534297A (ja) * | 2015-10-29 | 2018-11-22 | ノバルティス アーゲー | toll様受容体アゴニストを含む抗体コンジュゲート |
| US20190192668A1 (en) * | 2017-12-26 | 2019-06-27 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| WO2019195055A1 (en) * | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Implantable particles and related methods |
| JP2019529579A (ja) * | 2016-10-03 | 2019-10-17 | シギロン セラピューティクス, インコーポレイテッドSigilon Therapeutics, Inc. | 化合物、デバイスおよびその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2411197A (en) * | 1996-04-30 | 1997-11-19 | Affymax Technologies N.V. | Methods for the synthesis of fmoc protected amines |
| US20180185368A1 (en) * | 2014-11-06 | 2018-07-05 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
-
2021
- 2021-08-04 CA CA3190778A patent/CA3190778A1/en active Pending
- 2021-08-04 US US18/019,664 patent/US20230303502A1/en active Pending
- 2021-08-04 BR BR112023002132A patent/BR112023002132A2/pt unknown
- 2021-08-04 CN CN202180068241.8A patent/CN116322777A/zh active Pending
- 2021-08-04 AU AU2021321433A patent/AU2021321433A1/en active Pending
- 2021-08-04 WO PCT/US2021/044564 patent/WO2022031862A2/en not_active Ceased
- 2021-08-04 JP JP2023507667A patent/JP2023536633A/ja active Pending
- 2021-08-04 KR KR1020237007667A patent/KR20230048523A/ko active Pending
- 2021-08-04 EP EP21854105.0A patent/EP4192468A4/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012514009A (ja) * | 2008-12-31 | 2012-06-21 | アーデリクス,インコーポレーテッド | 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるnhe媒介性アンチポートを阻害するための組成物および方法 |
| JP2017524768A (ja) * | 2014-08-01 | 2017-08-31 | マサチューセッツ インスティテュート オブ テクノロジー | 抗線維化材料のための修飾されたアルギネートおよび用途 |
| WO2016071856A1 (en) * | 2014-11-06 | 2016-05-12 | Novartis Ag | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
| JP2018534297A (ja) * | 2015-10-29 | 2018-11-22 | ノバルティス アーゲー | toll様受容体アゴニストを含む抗体コンジュゲート |
| JP2019529579A (ja) * | 2016-10-03 | 2019-10-17 | シギロン セラピューティクス, インコーポレイテッドSigilon Therapeutics, Inc. | 化合物、デバイスおよびその使用 |
| US20190192668A1 (en) * | 2017-12-26 | 2019-06-27 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| WO2019195055A1 (en) * | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Implantable particles and related methods |
Non-Patent Citations (5)
| Title |
|---|
| "CAS REGISTRY No. 2419398-88-0", DATABASE REGISTRY [ONLINE], JPN7025002082, 2020, pages 2025 - 04, ISSN: 0005592381 * |
| HOWARTH, N. M. ET AL.: ""Synthesis of N-propynyl analogues of peptide nucleic acid (PNA) monomers and their use in the clic", TETRAHEDRON, vol. 67, no. 49, JPN6025019114, 2011, pages 9588 - 9594, ISSN: 0005592379 * |
| LU, G. ET AL.: ""An iterative route to "decorated" ethylene glycol-based linkers"", CHEMICAL COMMUNICATIONS, JPN6025019112, 2006, pages 1652 - 1654, ISSN: 0005592377 * |
| MARRA, A. ET AL.: ""Copper(I)-Catalyzed Azide-Alkyne Cycloadditions in Ionic Liquids under Amine-Free Conditions"", SYNTHESIS, vol. 2010, no. 12, JPN6025019113, 2010, pages 2043 - 2048, ISSN: 0005592378 * |
| TEKKAM, S. ET AL.: ""Synthesis and Reactivity of 5-Substituted Furfuryl Carbamates via Oxanorbornadienes"", ORGANIC LETTERS, vol. 19, no. 11, JPN6025019115, 2017, pages 2833 - 2836, ISSN: 0005592380 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022031862A2 (en) | 2022-02-10 |
| BR112023002132A2 (pt) | 2023-04-11 |
| KR20230048523A (ko) | 2023-04-11 |
| US20230303502A1 (en) | 2023-09-28 |
| EP4192468A4 (en) | 2024-09-11 |
| WO2022031862A3 (en) | 2022-03-24 |
| CA3190778A1 (en) | 2022-02-10 |
| EP4192468A2 (en) | 2023-06-14 |
| AU2021321433A1 (en) | 2023-03-02 |
| CN116322777A (zh) | 2023-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20230048523A (ko) | 헤테로아릴 및 헤테로사이클릴 화합물 | |
| JP7199739B2 (ja) | Gabaaの正のアロステリックモジュレーターの塩及び結晶形態 | |
| JP2021521163A (ja) | 標的タンパク質分解化合物、その抗腫瘍応用、その中間体および中間体の応用 | |
| JP6148594B2 (ja) | E1活性化酵素阻害剤の合成のためのプロセス | |
| AU2020350529B2 (en) | Cyano-substituted cyclic hydrazine derivative and application thereof | |
| TWI921403B (zh) | 雙環1,4-二氮雜環庚酮及其治療用途 | |
| US20250376432A1 (en) | Process for preparing modulators of eukaryotic initiation factor 2b | |
| JP2026516129A (ja) | Wee1-Yes二重標的阻害剤としてのピリミドマクロ複素環式化合物及びその応用 | |
| CN104619702A (zh) | Ccr2的稠合环戊基拮抗剂 | |
| JP2022507361A (ja) | オレキシン受容体調節因子としての縮合複素環式化合物を作製する改良された合成方法 | |
| Kumar et al. | Sacrificial azomethine ylide cycloaddition controlled chemoselective nitrile oxide cycloaddition to 1-methyl-3, 5-bis [(E)-arylmethylidene] tetrahydro-4 (1H)-pyridinones: formation of mono-spiro-isoxazolines | |
| KR20180128907A (ko) | 면역조절제로서 작용하는 트리시클릭 화합물 (tricyclic compound serving as immunomodulator) | |
| JP6940480B2 (ja) | Fgfr阻害剤の合成方法 | |
| CA3163920A1 (en) | Tetrahydrobenzo-quinoline sulfonamides derivative compounds | |
| JP2022531936A (ja) | イミダゾ[1,2-a]ピリミジンの位置選択的合成 | |
| ES2977277T3 (es) | Procesos para preparar (3R,4R)-1-bencil-n,4-dimetilpiperidin-3-amina o una de sus sales y procesos para preparar tofacitinib mediante el uso de la misma | |
| Huszthy et al. | Efficient synthesis of azetidine through N‐trityl‐or N‐dimethoxytritylazetidines starting from 3‐amino‐l‐propanol or 3‐halopropylamine hydrohalides | |
| JP2025030529A (ja) | 重水素化化合物の製造方法 | |
| Sheldrick et al. | 5-Ethoxycarbonyl-3, 4'-diethyl-4, 3', 5'-trimethyl-2, 2'-dipyrrolyl ketone | |
| JPH05186437A (ja) | 縮合ピリミジン誘導体 | |
| Jaskólski et al. | Synthesis and crystal and molecular structure of 1, 2-Di (N-piperidyl) ethane-bis-N-oxide tetrahydrate | |
| WO2017108927A1 (en) | Process for preparation of ingenol 3-(3.5-diethylisoxazole-4-carboxylate) | |
| JPH0321609A (ja) | 有機ホウ素含有ポリマー | |
| JPS58124719A (ja) | 抗腫瘍剤 | |
| Wang | Syntheses and characterizations of new polymers with bile acid derivatives as pendant groups |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230317 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20230317 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240805 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240805 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250513 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250515 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250812 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251010 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251209 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260408 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20260529 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260601 |